BIOLIFE SOLUTIONS INC (BLFS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q1 '21: 16.8M Q2 '21: 31.2M Q3 '21: 33.8M Q4 '21: 37.3M Q1 '22: 36.2M Q2 '22: 40.5M Q3 '22: 40.7M Q1 '23: 37.7M Q2 '23: 29.2M Q3 '23: 23.6M Q1 '24: 18.4M Q2 '24: 19.7M Q3 '24: 21.4M Q4 '24: 15.1M Q1 '25: 22.1M Q2 '25: 23.4M Q3 '25: 28.1M Q4 '25: 18.8M Q1 '26: 27.5M Q2 '26: 28.5M Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q4 '15: 1.1M Q1 '16: 1.1M Q2 '16: 1.1M Q3 '16: 1.2M Q4 '16: 1.4M Q1 '17: 1.4M Q2 '17: 1.6M Q3 '17: 1.9M Q4 '17: 1.8M Q1 '18: 2.5M Q2 '18: 3.6M Q3 '18: 3.7M Q4 '18: 3.7M Q1 '19: 4.1M Q2 '19: 4.7M Q3 '19: 4.5M Q1 '25: 14.8M Q2 '25: 15.2M Q1 '26: 17.5M Q2 '26: 18.3M Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q1 '25 Q2 '26

Operating Income Quarterly

-90M -60M -30M 0 30M 60M 90M Q2 '21: -4.6M Q3 '21: -11.2M Q4 '21: -18.5M Q1 '22: -8M Q2 '22: -76.6M Q3 '22: -11.7M Q1 '23: -13.6M Q2 '23: -10.6M Q3 '23: -15.5M Q4 '23: 22.5M Q1 '24: -3.3M Q2 '24: -1.3M Q3 '24: -418K Q4 '24: 542K Q1 '25: -499K Q2 '25: -16.1M Q3 '25: -89K Q4 '25: 112K Q1 '26: 27K Q2 '26: 1.7M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q2 '21: 7.9M Q3 '21: 79K Q4 '21: -15.7M Q1 '22: -7.4M Q2 '22: -72.9M Q3 '22: -10.3M Q4 '22: -49.2M Q1 '23: -13.7M Q2 '23: -10.2M Q3 '23: -29.1M Q4 '23: -15M Q1 '24: -10.2M Q2 '24: -20.7M Q3 '24: -1.7M Q4 '24: 12.5M Q1 '25: -448K Q2 '25: -15.8M Q3 '25: 621K Q1 '26: 1.2M Q2 '26: 45.1M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 3.5M 7M 10.5M Q4 '16: 883.5K Q1 '17: 928.4K Q2 '17: 956.8K Q3 '17: 1.1M Q4 '17: 1.3M Q1 '18: 1.4M Q2 '18: 1.5M Q3 '18: 1.6M Q4 '18: 1.7M Q1 '19: 1.6M Q2 '19: 2M Q3 '19: 2.1M Q4 '19: 3M Q1 '20: 4.6M Q2 '20: 4.5M Q3 '20: 4.8M Q1 '25: 7.3M Q2 '25: 8.2M Q1 '26: 10M Q2 '26: 10.2M Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: 2.1M Q4 '21: -774K Q1 '22: -7.9M Q2 '22: -9.9M Q3 '22: 1.5M Q4 '22: 7.9M Q1 '23: -2.7M Q2 '23: -7.7M Q3 '23: -4.4M Q4 '23: 2.3M Q1 '24: -4.5M Q2 '24: 6.5M Q3 '24: 4.8M Q4 '24: 1.6M Q1 '25: 1.7M Q2 '25: 7.4M Q3 '25: 6.1M Q4 '25: 4.9M Q1 '26: -491K Q2 '26: 6.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '20: 541K Q2 '20: 4.1M Q3 '20: -621K Q4 '20: 666K Q1 '21: 100K Q2 '21: -10.4M Q3 '21: -329K Q4 '21: -2.3M Q1 '22: -9.4M Q2 '22: -12M Q3 '22: -950K Q4 '22: 3.4M Q1 '23: -6M Q2 '23: -8.3M Q3 '23: -5.9M Q4 '23: 1.3M Q1 '25: 1.6M Q2 '25: 5.6M Q1 '26: -658K Q2 '26: 5.3M Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 21M Q2 '20: 23.3M Q3 '20: 31.6M Q1 '21: 33.2M Q2 '21: 40.4M Q3 '21: 43.3M Q1 '22: 42M Q2 '22: 42.5M Q3 '22: 42.6M Q1 '23: 43M Q2 '23: 43.4M Q3 '23: 43.6M Q1 '24: 45.4M Q2 '24: 46M Q3 '24: 46.2M Q1 '25: 48.4M Q2 '25: 47.8M Q3 '25: 48.7M Q1 '26: 49.2M Q2 '26: 49.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '17: -0.21 Q1 '21: -0.84 Q2 '21: 0.05 Q3 '21: 0.09 Q4 '21: -0.24 Q1 '22: -0.39 Q2 '22: -2.30 Q3 '22: -2.54 Q4 '22: -3.25 Q1 '23: -3.39 Q2 '23: -1.90 Q3 '23: -2.33 Q4 '23: -1.55 Q1 '24: -1.45 Q2 '24: -1.67 Q3 '24: -1.04 Q4 '24: -0.44 Q1 '25: -0.22 Q2 '25: -0.10 Q3 '25: -0.05 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.